Language
English
Publication Date
5-7-2021
Journal
Current Cardiology Reports
DOI
10.1007/s11886-021-01501-7
PMID
33961122
PMCID
PMC8102148
PubMedCentral® Posted Date
5-7-2021
PubMedCentral® Full Text Version
Post-print
Abstract
PURPOSE OF REVIEW: To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic.
RECENT FINDINGS: The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far. There has been considerable evidence suggesting that COVID-19 increases the risk of acute coronary syndromes (ACS). We propose characterizing ACS patients into 3 distinct categories to better assist in appropriate triage and management: critically ill patients, non-critically ill ST elevation myocardial infarction (STEMI) patients, and non-critically ill non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) patients. We thoroughly review treatments strategies, management considerations, and current consensus statements for the care of COVID-19 patients with ACS. As we continue to gain more experience with management of COVID-19 in ACS patients and as health-care workers and patients continue to get vaccinated, we must continue to adapt our strategies to treat this high-risk group of patients.
Keywords
COVID-19, Acute coronary syndrome, Cardiac catheterization, Health personnel, Personal protective equipment, ST elevation myocardial infarction
Published Open-Access
yes
Recommended Citation
Borgaonkar, Sanket; Hahn, Joshua; Daher, Marilyne; et al., "Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era" (2021). Faculty and Staff Publications. 994.
https://digitalcommons.library.tmc.edu/baylor_docs/994
Included in
Cardiology Commons, Cardiovascular Diseases Commons, COVID-19 Commons, Epidemiology Commons, Medical Sciences Commons